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Abstract   38 
 39 
Background: Malnutrition is common in Inflammatory Bowel Disease (IBD) and is associated 40 
with poor health outcomes. Despite this, screening for malnutrition in the outpatient-setting is 41 
not routine and research in the area is limited.  This study aimed to evaluate whether agreement 42 
between malnutrition screening completed by patients and Healthcare Professionals (HCP’s) 43 
could be achieved by comparing patient self-administered ‘MUST’ (‘MUST’-P) to HCP  44 
administered ‘MUST’ (‘MUST’-HCP) in a single tertiary IBD outpatient clinic. 45 
 46 
Methods: We conducted a feasibility and validity study on adult outpatients with IBD.  We 47 
collected anthropometric, nutritional and clinical data from patients.  All patients completed 48 
‘MUST’-P using a self-administered questionnaire, followed by ‘MUST’-HCP. ‘MUST’-P 49 
was timed and feedback on ease-of-use was obtained.  Malnutrition risk was classified as low 50 
(score=0), medium (score=1), and high (score≥2) and agreement tested using kappa statistics 51 
(κ).  52 
 53 
Results: Eighty patients were recruited (Crohn’s Disease:n=49, Ulcerative Colitis:n=29, 54 
Unclassified:n=2), with mean age 39.9±SD:15.1yrs, 51.2% were males.  Seventy one (92%) of 55 
patients found ‘MUST’-P either easy or very easy. The mean time to complete ‘MUST’-P was 56 
3.1±1.8min (range 1-10min). Sixty-eight (85%) of patients were at low risk of malnutrition 57 
when screened by the HCP.  There was moderate agreement (κ=0.486, p<0.001) between 58 
‘MUST’-P and ‘MUST’-HCP with 100% agreement in scoring for medium- and high-risk 59 
categories.   60 
 61 
Conclusions: Our study suggests that self-screening using ‘MUST’ could be effectively used 62 
in an IBD outpatient clinic to identify those at medium and high risk of malnutrition. The 63 
patient friendly version of ‘MUST’;‘MUST’-P was considered quick and easy to use by 64 
patients.   Implementation of self-screening with ‘MUST’ could improve the nutritional 65 
management of IBD patients. 66 
  67 
 68 
 69 
 70 
  
 71 
 72 
Introduction (maximum 2 pages)  73 
 74 
Malnutrition can be defined as “a state of nutrition in which deficiency, excess or imbalance 75 
of energy, protein, and other nutrients causes measurable adverse effects on tissue and body 76 
form (body shape, size, composition), function and clinical outcome” (1,2).  It is a serious and 77 
common condition associated with significant morbidity and mortality, affecting adults and 78 
children with all types of diseases in all health care settings. Prevention, identification and 79 
treatment of malnutrition at an early stage could reduce potential health risks, dependency on 80 
others, hospital admissions and costs (3,4).  The economic impact of malnutrition risk due to 81 
increased use of health and social care resources, hospitalisation and length of hospital stay as 82 
identified using tools including ‘MUST’ is well documented (5-6).  A study conducted in 83 
Portugal on 637 inpatients found that high risk of malnutrition in 21-29% patients, identified 84 
using malnutrition screening tools, was an independent predictor of increased hospitalisation 85 
costs (7). NICE recommend that all outpatients should be screened for malnutrition at their first 86 
appointment and screening should be repeated when there is clinical concern (8).  87 
 88 
Crohn’s disease (CD) and Ulcerative Colitis (UC) are the main types of Inflammatory Bowel 89 
Diseases (IBD), with a rarer type (Unclassified IBD-U) accounting for approximately 10% of 90 
all cases (9).   In a northern English population the prevalence of IBD has been estimated at 91 
approximately 387 per 100, 000 population (243 per 100,000 with UC and 144 per 100,000 with 92 
CD) in 1995, with the prevalence of CD increasing faster than UC (10). IBD is associated with 93 
substantial morbidity, one aspect includes nutritional status where malnutrition and weight loss 94 
are common (11-12). Up to 75% of adults with active IBD are malnourished (13-15) and up to 95 
33% of adults in remission have been found to be malnourished (16). IBD patients often alter 96 
their eating habits to alleviate their symptoms, potentially leading to malnutrition and weight 97 
loss (17). In addition to protein-energy malnutrition, deficiencies in trace elements and vitamins 98 
such as magnesium, iron and vitamin B12 are common (18-19). Prolonged symptoms as well as 99 
the disease management either by drug treatment or surgery may further impact on the 100 
nutritional status of patients.   101 
 102 
Food and nutrition is viewed as a high priority for IBD patients (20) yet dietetic service 103 
provision remains poor with approximately 60% of inpatients receiving no dietetic contact (21). 104 
Malnutrition can be under-recognised in IBD patients as routine screening is not common 105 
  
practice, resulting in under-detection and thus under-treatment of malnutrition (22,23). Factors 106 
contributing to this include: lack of recognition of the detrimental effects of malnutrition in 107 
IBD, difficulties implementing nutritional plans, lack of staffing in busy outpatient clinics and 108 
lack of guidance on the management of those identified at risk of malnutrition (21). A systematic 109 
review looking at barriers and facilitators of adoption of nutritional screening by nurses 110 
concluded that it was unlikely, unless it was considered an integral part of the nursing 111 
assessment and was appropriate resourced (24).  The use of patient self-administered 112 
malnutrition screening tools has been shown to be beneficial in the hospital outpatient setting 113 
(25).   114 
 115 
The UK IBD Audit (21) advises that all IBD inpatients are screened for malnutrition and 116 
recommend ‘MUST’ as an appropriate tool. In addition, while nutritional screening guidelines 117 
exist for a variety of health care settings (26) no specific screening tool has been developed for 118 
IBD outpatients.  Patient administered self-screening has recently been investigated in different 119 
studies and has demonstrated benefits in various disease states (1,22,25,27).   120 
 121 
The ‘MUST’ tool is considered an appropriate malnutrition screening tool as it has face-, 122 
content-, concurrent- and predictive- validity with a range of other screening tools.  It is also 123 
internally consistent and reliable and has very good to excellent reproducibility when used with 124 
different assessors in a variety of settings. Guerra et al (7) found agreement between ‘MUST’ 125 
and the ESPEN (European Society of Parenteral and Enteral Nutrition) recommended Nutrition 126 
Risk Screening tool (26) as a predictor for increased hospitalisation costs. The ‘MUST’ tool has 127 
been found to be easy, quick to use and acceptable to patients, research-participants and 128 
healthcare workers (28-29). Previous research examining self-screening in outpatients is either 129 
not IBD specific (1, 27, 28) or has not been conducted in the UK population (22). 130 
 131 
This study aims to assess feasibility (completion time and ease of use) and validity of ‘MUST’-132 
P compared to risk classification obtained by ‘MUST’-HCP in IBD outpatients.   This research 133 
has the potential to improve patient care by contributing to the malnutrition risk identification, 134 
which impacts not only on the disease related complications but also on healthcare costs (30). 135 
Nutritional support to treat malnutrition may improve symptoms and allow deficiencies in 136 
calories as well as macro and micro-nutrients to be rectified (18). 137 
 138 
 139 
Materials and Methods  140 
  
Study design and population  141 
This is a feasibility and validity study (31). Eighty three patients in the adult IBD outpatient 142 
clinic at UCLH were approached from the waiting area using convenience sampling over an 8-143 
week period between May 2015 and July 2015.  The inclusion criteria were patients with a 144 
confirmed IBD diagnosis and ≥ 18 years of age.  Exclusion criteria were unwillingness or 145 
inability to provide informed consent and inability to communicate in the English language. 146 
Patients accompanied by a relative able to translate or act as an interpreter were recruited.  147 
Every effort was made to recruit all eligible patients to minimise selection bias.  However three 148 
patients declined the invitation to participate, making the sample size eighty patients. 149 
 150 
Ethical approval was sought from London Metropolitan University Ethics Committee and by 151 
the University College London Hospital research and development committee. Full ethical 152 
approval was not required as the study was deemed part of service evaluation. Written informed 153 
consent was obtained from all study participants and patients were assured of confidentiality 154 
and anonymity. 155 
 156 
Data Collection 157 
The tools utilised for the data collection were the patient administered screening tool (‘MUST’-158 
P) followed by the ‘MUST’ tool completed by the researcher (‘MUST’-HCP) to screen the 159 
participants for malnutrition. Using routinely collected data from electronic databases and 160 
paper medical records information was collected on the characteristics of the patient group, 161 
including: demographics (date of birth, gender); anthropometry (height, weight and weight 162 
changes) and IBD type and date of diagnosis obtained from medical records.  Well-being was 163 
taken from validated tools to measure disease activity in IBD: the Harvey Bradshaw Index (32) 164 
for CD and the Simple Clinical Colitis Activity Index (33) for UC which measures wellbeing 165 
on a 5-point likert scale from “very well” (0) to “terrible” (4).  Referral to a Dietitian since 166 
diagnosis was also obtained. Area deprivation was based on national specific data of multiple 167 
deprivation rank from 2015, a composite score including income; employment; education, 168 
training and skills; health deprivation and disability; crime, barriers to housing and services; 169 
and living environment deprivation, with 1 missing value as one patient’s postcode could not 170 
be assigned a deprivation score (34).  The research team consisted of two qualified dietitians. 171 
 172 
 173 
Malnutrition Tools  174 
‘MUST’-P 175 
  
Patients were provided with a simple instruction sheet, BMI chart and weight loss tables.   The 176 
HCP recorded the length of time the patient took to complete the tool. The patients were asked 177 
initially to complete the ‘MUST’-P independently. The ‘MUST’-P was the ‘MUST’ tool 178 
developed by Cawood et al (27) who adapted ‘MUST’ for patient use in a hospital outpatient 179 
setting.  The BMI and weight loss charts were used from the British Association for Parenteral 180 
and Enteral Nutrition (BAPEN) tool kit (35).  Following completion of the ‘MUST’-P the 181 
patient was asked to rate the ease-of-use of the ‘MUST’-P tool on a Likert scale (very difficult 182 
to very easy) and time for completion in minutes was estimated by the patient.  183 
 184 
Health care professional ‘MUST’ (‘MUST’-HCP) 185 
The screening was completed by a trained HCP researcher using the BAPEN resources (35). 186 
Weighing scales and a stadiometer were both available in the clinic.  Patients’ height and 187 
weight was measured by a trained HCP and documented in the medical notes.  The patients 188 
were informed of their weight and height.  189 
 190 
Statistical analysis 191 
Frequencies and percentages (%) were used to describe categorical variables. Mean, standard 192 
deviation (SD) and range (minimum and maximum) were used to describe continuous 193 
variables. Area deprivation was categorised as ‘least’ and ‘most’ by using the median of the 194 
national index of multiple deprivation rank. Risk scores from both administrations of ‘MUST’ 195 
were classified as low (score=0), medium (score=1), and high (score>2) risk, from which 196 
sensitivity and specificity was calculated. Agreement between the two tools was assessed using 197 
kappa statistics. The kappa coefficient (κ) was interpreted using the grading system of Landis 198 
and Koch (<0=no agreement; 0-0.20=slight; 0.21-0.40=fair; 0.41-0.60=moderate; 0.61-199 
0.80=substantial; 0.81-1=almost perfect agreement) (36). In sensitivity analyses, we examined 200 
whether patient characteristics; age (young vs. old); gender (men vs. women); and IBD 201 
duration (short vs. long) would influence agreement between ‘MUST’-P and ‘MUST’-HCP.  202 
 203 
Differences in demographic variables by IBD status (CD vs. UC) were presented by mean (SD) 204 
for normal continuous data and n (%) for categorical data, and tested using T-test and Chi-205 
squared tests, respectively.  P-values were two-tailed and set at a significance level of 0.05. 206 
Statistical Analysis was conducted using STATA version 14 [StataCorp, College Station, TX]. 207 
  
Results 208 
Study population  209 
Table 1 shows the demographic and clinical characteristics of the 80 IBD patients who 210 
participated in the study. Overall, the study sample consisted of 51.2% males and the mean age 211 
of participants was 39.9 ± 15.1 years old (range 19-84). The majority of the participants n=49 212 
(61.3%) had CD. No demographic or clinical characteristics were significantly different by 213 
IBD status except area deprivation where those with CD were least likely to live in a deprived 214 
area compared to UC patients (p=0.01).  However, there was a non-significant trend towards a 215 
lower BMI in the CD versus UC group.  In total one UC patient had active disease and 3 CD 216 
patients had active disease (2 mild and 1 moderate).  217 
 218 
Agreement between ‘MUST’-P and ‘MUST’-HCP screening  219 
Of the eighty IBD patients included in the study, three patients (3.8%) refused to complete the 220 
‘MUST’-P for the following reasons; one due to eye sight difficulties, one considered that it 221 
should be done by a HCP, and one did not state a reason.  Thus, the total sample size included 222 
for agreement analysis of ‘MUST’-P and ‘MUST’-HCP is n=77.   223 
 224 
There was 100% sensitivity for patients who were at medium or high risk using the ‘MUST’-225 
P tool compared to the ‘MUST’-HCP tool.  However, specificity was somewhat lower in that 226 
2 were scored as medium risk and 15 patients scored as high risk using ‘MUST-P’, whereas 227 
they were scored as low risk using ‘MUST’-HCP. Overall, this meant that there was moderate 228 
agreement between the ‘MUST’-P and ‘MUST’-HCP scores as determined by the kappa 229 
statistic (κ= 0.486, p<0.001). We found no evidence that agreement between ‘MUST’-P and 230 
‘MUST’-HCP was affected by stratification by age, gender, or IBD duration.  231 
 232 
Ease of use and time to complete ‘MUST’-P 233 
Overall, 51.9% (n=40) of patients’ reported the completion of ‘MUST’-P as easy; 40.2% 234 
(n=31) rating it as very easy; 6.5% (n=5) as difficult and 1.3% (n=1) as very difficult.  The 235 
average time for the completion of the questionnaire was 3.1 ± 1.8 min (range 1-10 min). 236 
 237 
 238 
Prevalence of malnutrition assessed by ‘MUST’-P 239 
A comparison of the malnutrition risks as identified by the patients themselves and the 240 
researcher is shown in Table 2. There was 100% agreement between ‘MUST-P and ‘MUST’-241 
HCP for all patients with medium and high malnutrition risk. However, this reduced to 74.3% 242 
  
agreement with the ‘MUST’-HCP score in the low risk category. This was due to 17 243 
discrepancies with low risk categories, mostly associated with difficulty reading the BMI chart 244 
22.7% (n=15) and 3% (n=2) were related to the weight loss score.  245 
  246 
The proportion of participants with medium and high risk scores of malnutrition was 247 
explored using the ‘MUST’-HCP. The results show similar proportions of the sample in the 248 
medium and high risk malnutrition categories:  8.8% (n= 7 patients) at medium risk- and 249 
6.3% (n= 5 patients) at high risk- of malnutrition when screened by the researcher.  Of the 250 
patients in the study at high risk of malnutrition 2 out of 5 had not been referred to a dietitian 251 
since diagnosis and 1 out of 5 had seen a dietitian but did not arrange a follow-up. In total 50 252 
patients (62.5%) had seen a Dietitian since diagnosis. The majority of patients (91.3%) had a 253 
BMI score 0 in the initial part of the ‘MUST’. 71 patients (88.8%) had minimal weight loss 254 
(5%) in the past 6 months and all the patients (100%) were not acutely ill while completing 255 
the study.  256 
 257 
Outcomes of the three steps of ‘MUST’ used by the researcher to identify malnutrition  258 
The ‘MUST’-HCP identified that of 80 patients screened, 85% (n=68) 8.8% (n=7) and 6.3% 259 
(n=5) were at low risk, medium risk, and high risk of malnutrition, respectively.   91.3% (n=73) 260 
of patients had a low risk BMI, 3.8% (n=3) medium risk and 5% (n=4) high risk.  85% (n=68) 261 
of patients had no weight loss.  Of the 15% with weight loss, 88.8% (n=71) had <5%, 8.8% 262 
(n=7) 5-10% and 2.5% (n=2) >10% weight loss. None of the patients were deemed acutely 263 
unwell. One patient at medium risk and one patient at high risk using ‘MUST’-HCP had 264 
moderately active disease.   265 
 266 
Discussion  267 
Overall, the results showed that ‘MUST’-P can be used to capture medium and high 268 
malnutrition risk in the IBD outpatient setting.  If accurately implemented this could be 269 
included in patients’ nutritional assessments. This bridges a gap in knowledge, as there is 270 
limited research to date exploring use of self-screening in IBD outpatients, particularly from 271 
UK based studies.  272 
 273 
Accuracy of tool and ease of use of ‘MUST’-P 274 
Patient self-screening has been found to be an easy and well accepted tool, generating precise 275 
measurements compared with those made by a HCP (25). Our study found a moderate 276 
agreement between ‘MUST’-P and ‘MUST’-HCP (κ coefficient= 0.486, p< 0.001), such that 277 
  
100% of IBD patients with medium and high risk of malnutrition were identified by the patient 278 
and the HCP; providing confidence in using a patient administered tool.  279 
 280 
However, 17 ‘MUST’-P related discrepancies were identified, mainly relating to difficulty 281 
reading the BMI chart.   In addition, there was no influence of age, gender and IBD duration 282 
on agreement between ‘MUST’-P and ‘MUST’-HCP. Other studies have found the 283 
discrepancies between HCP and patient self-screening were mostly associated with the weight 284 
loss and BMI score (22,27). The use of mobile technology for calculating ‘MUST’ scores could 285 
help facilitate the implementation of ‘MUST’-P by improving its accuracy and ease of use for 286 
patients, thus improving compliance.  McGurk et al (25) investigated ‘MUST’ self-screening 287 
using digital technology to calculate BMI in a gastroenterology outpatient clinic.  All patients 288 
were able to self-screen and there was perfect agreement in test-retest reliability between the 289 
patient and dietitian suggesting that use of digital screening may produce more accurate results.  290 
 291 
Based on previous published studies, with the exception of reports from McCurk et al (25), the 292 
majority of IBD patients reported the completion of ‘MUST’-P as either easy or very easy.  293 
This study is consistent with previous findings by Sandhu et al (22) where 96% of IBD patients 294 
rated self ‘MUST’ screening as either easy or very easy to understand and complete. 295 
 296 
This study used a patient friendly version of ‘MUST’ adapted from Cawood et al (27). In our 297 
study the average time for completion was 3.1 ± 1.8 min (range 1-10 min) and 100% completed 298 
the tool in 5 minutes or less. Cawood et al (27) found 75% of 205 outpatients were able to screen 299 
themselves in less than 5 minutes and rated the self-screening as easy or very easy.  In a 300 
Canadian study (22) of 154 IBD adult outpatients, all patients were able to self-screen and 96% 301 
reported the tool as either easy or very easy to use. Cawood et al (27) observed that the overall 302 
prevalence of malnutrition (medium and high risk) was similar between self-screening (19.6%) 303 
and HCP screening (18.6%) which correlated well with our study findings. 304 
 305 
 306 
Prevalence of Malnutrition 307 
Our study suggests that the prevalence of malnutrition in the IBD outpatient-setting at UCLH 308 
is low compared to other published studies (13-16).  This is possibly enhanced by close 309 
monitoring by an IBD multidisciplinary team.  However, due to the small size in our study 310 
these results should be viewed with caution. When screened by the HCP the majority of patients 311 
(85%) were at low risk of malnutrition, with 8.8% and 6.3% of the sample at medium and high 312 
  
risk, respectively. Seventy one patients reported less than 5% of weight loss in the last 6 months 313 
and had a low-risk BMI.   314 
Few studies to date have specifically looked at prevalence of malnutrition in IBD outpatients.  315 
Vadan et al., (15) found that 59.3% of 30 patients attending a Gastroenterology Clinic in 316 
Bucharest were malnourished, whereas, in a UK based study (29) there was a high prevalence 317 
of malnutrition identified in general gastroenterology outpatients using different tools 318 
including ‘MUST’.  Interestingly, in this study the mean BMI score indicated the UC patients 319 
were overweight (mean BMI: 27.6kg/m2) and CD patients were at the upper end of the healthy 320 
weight range (mean BMI: 25.3kg/m2).  Obesity as well as increased fat mass has been 321 
associated with elevated inflammatory markers and a more severe disease course in CD 322 
patients (37-38).  Although ‘MUST’ is able to detect higher proportions of malnutrition risk 323 
compared to BMI alone, basic anthropometry is insufficient to differentiate fat mass and lean 324 
body mass.  In a prospective controlled study among IBD patients, despite 74% of IBD patients 325 
having a normal BMI, handgrip strength and lean body mass was impaired in both CD and UC 326 
patients (39).  More than half of IBD patients were found to have muscle mass depletion despite a 327 
normal BMI (40) as IBD not only causes weight change it also alters body composition. 328 
Assessment of body composition in addition to simple anthropometry would better indicate 329 
nutritional status in IBD patients. 330 
Specific micronutrient deficits, loss of body cell mass and muscle strength often persist even 331 
in disease remission and would not be detected by standard malnutrition screening alone (39). 332 
In the IBD cohort it may not be possible to fully evaluate malnutrition risk based solely on 333 
malnutrition screening, due to the complex nature of the disease.   334 
 The Bioelectrical Impedance Analysis (BIA) is a measure of body composition that can be 335 
used to differentiate between fat and fat free mass and is also a predictor for nutritional status 336 
(40).  BIA is used in clinical settings as it is considered to be non-invasive, no technical skill is 337 
required and it is comfortable for patients compared to other methods.  However, BIA is expensive 338 
and time consuming and due to time and staffing constraints in a busy outpatient setting a more 339 
economic and practical measurement of body composition is required.    340 
Tricep Skinfold thickness (TSF) is the most frequently used method for assessment of body 341 
composition as it is cheap and feasible.  Body fat can be predicted by the sum of skinfold thickness 342 
from different parts, as the total body fat correlates with subcutaneous fat (41). TSF has been found 343 
to correlate well with BIA in a study which evaluated the body fat estimated by BIA and TSF on 344 
  
348 undergraduate students and concluded that the anthropometric method can surrogate fat mass 345 
% and  assess body fat when BIA is unavailable (42). The addition of TSF may be useful to 346 
support ‘MUST’ in identifying malnutrition risk in the IBD patient cohort. However, the 347 
acceptability of this additional measure in the IBD patient group would require further testing 348 
in clinical practice.  349 
Implications  350 
Implementing ‘MUST’-P could potentially reduce the workload demands on HCP’s to screen 351 
patients for identification of malnutrition risk of patients in the outpatient setting. Furthermore, 352 
the use of self-screening has the capacity to promote patient involvement in their own care.  353 
However, due to the complex nature of IBD there are concerns that using a generic malnutrition 354 
screening tool may not capture all patients at malnutrition risk.  It may be that screening in the 355 
community is a more appropriate setting for ‘MUST’ where rates of under-recognised and 356 
under-treated malnutrition are known to be high (35).  Patients could be advised to use the web-357 
based malnutrition self-screening tool based on ‘MUST developed and available on the 358 
BAPEN website (35) which is designed to help adults to identify their own risk of malnutrition 359 
in the community.  360 
 361 
Recommendations for further research 362 
In order to be able to generalise these findings to the wider IBD population, larger studies are 363 
required in different UK hospital outpatient settings.   364 
 365 
The use of HCP led focus groups could be used to explore perceptions of ‘MUST’-P and help 366 
to identify the potential barriers and facilitators of its use develop the tool further and improve 367 
its accuracy and validity.  To enable successful implementation of ‘MUST’-P in the outpatient 368 
setting, appropriate and practical malnutrition care pathways would need to be developed so 369 
that those identified as malnourished are appropriately managed and treated. However, dietetic 370 
resourcing available for those patients identified at high risk may be a limiting factor. 371 
 372 
Limitations 373 
Test-retest reliability was performed both by Cawood et al (27) and McCurk et al (25) in order 374 
to compare the accuracy of two different self-screening scores.  Similar to the work of Sandhu 375 
et al (22), this study did not perform test-retest reliability as there would be a short duration of 376 
time between baseline ‘MUST’-P and repeat screening and it is highly likely the patients would 377 
recall their baseline score, potentially introducing reporting bias.   Only 3 patients approached 378 
  
refused to complete ‘MUST’-P indicating a high response rate. The sample size of 80 compares 379 
favourably to other studies in IBD cohorts (20).  A limitation of the validity of the study was 380 
that due to the low numbers of patients with active disease, it was not possible to assess whether 381 
there was a significant relationship between disease activity and ‘MUST’ score.  The results of 382 
our study correlate well with a previous larger study in a similar patient cohort (22).  However, 383 
the results of our study cannot be generalised to the wider population due to the small sample 384 
size which was restricted to a single UK based large tertiary hospital.   385 
 386 
Conclusions  387 
This study confirms previous findings that suggest ‘MUST’-P is a quick and easy method of 388 
nutritional screening for use in a busy outpatient setting. Moderate agreement was found 389 
between ‘MUST’-HCP and ‘MUST’-P with the strongest agreement for medium and high risk 390 
patients.  Although the overall malnutrition rates were found to be low, not all patients 391 
recognised as at high risk of malnutrition by ‘MUST’-HCP were referred to the Dietitian.  392 
Furthermore, due to the complexity of nutritional issues specific to IBD patients the use of a 393 
generic tool may risk missing patients deemed as low risk that may still require nutritional 394 
intervention.  The authors recommend that to ensure all nutritionally at risk patients are 395 
identified, this tool is combined with measurement of body composition and consideration of 396 
micronutrient serum levels. Frequent and regular nutritional screening in all health care settings 397 
will allow the malnutrition risk to be identified early and be prevented or treated appropriately. 398 
 399 
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Table 1: Demographic and Clinical Characteristics of the study participants (total n=80).  582 
Table 2: Comparison of malnutrition risks as identified by the MUST-P and the MUST-HCP 583 
(total n=77) 584 
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Table 1: Demographic and Clinical Characteristics of the study participants (total n=80).  587 
Characteristic  UC  
% (n)  
36.2 (29) 
 
CD*  
% (n)  
61.3 (49) 
 
Comparison 
of UC and 
CD  
P value  
IBD-U 
2.5 (2) 
Total IBD 
cohort 
(n=80) 
Age: mean (SD) 
years 
 
43.1  
(16.2) 
37.8  
(14.6) 
0.14 45  
(5.7) 
39.9  
(15.1) 
 
Gender (n,%)  
Female 
Male  
 
 
14 (48.3) 
15 (51.7) 
 
 
23 (46.9) 
26 (53.1) 
 
0.91 
 
2 (100.0) 
0 (0.0) 
 
39 (48.8)  
41 (51.2) 
Time since 
diagnosis (n,%) 
≤ 10 years  
>10 years  
 
 
17 (58.6) 
12 (41.4) 
 
 
 
28 (57.1) 
21 (42.9) 
0.90  
 
2 (100.0) 
0 (0.0) 
 
 
47 (58.8) 
33 (41.2) 
Well-being 
(n,%)** 
0 (very well) 
1 (slightly below 
average) 
2 (poor) 
3 (very poor) 
4 (terrible) 
0=11(37.9) 
1=17(58.6) 
2=1(3.5) 
3=0 (0.0) 
4=0 (0.0) 
 
0=20 (40.8) 
1=22 (44.9) 
2=4 (8.2) 
3=2 (4.1) 
4=1 (2.0) 
0.80 0=1 (50.0) 
1=0 (0.0) 
2=0 (0.0) 
3=1 (50.0) 
0=32 
(40.0) 
1=39 
(48.8) 
2=5 (6.2) 
3=3 (3.8) 
4=1 (1.2) 
Height (m) 
mean (SD) 
 
1.71  
(0.09) 
1.71  
(0.08) 
0.75 1.54 
(0.11) 
1.71  
(0.09) 
Weight (kg)  
mean (SD) 
 
81.7  
(20.9) 
74.2  
(19.5) 
0.12 50.1  
(9.3) 
76.3  
(20.4) 
 
BMI (kg/m²) 
mean (SD) 
 
27.6  
(6.0) 
25.3  
(5.8) 
0.10 20.9 
(1.0) 
26  
(5.89)  
 
Area (n,%) 
Deprivation*** 
Most deprived 
Least deprived   
 
 
23 (79.3) 
6 (20.7) 
 
 
24 (50.0) 
24 (50.0) 
 
 
0.01 
 
 
1 (50.0) 
1 (50.0) 
 
 
48 (60.8) 
31(39.2) 
Data are presented as mean (SD), n(%), using unpaired t-test and Chi-square test to test for 588 
differences by IBD group. P-values represent differences between subgroups UC and CD only. 589 
*including Crohn’s Colitis 590 
** Well-being variable was categorised as very well (score 0) versus all other scores (1-4) 591 
when compared by IBD group using the Chi square test  592 
***Area deprivation variable includes n=1 missing value  593 
Abbreviations: BMI, body mass index; IBD, Inflammatory Bowel Disease 594 
 595 
  596 
  
Table 2: Comparison of malnutrition risks as identified by the  MUST-P and the MUST-HCP 597 
(total n=77) 598 
 Malnutrition Risk by  MUST-P Tot
al 
 Low Medium High  
 N % N % N % N 
Malnutriti
on Risk by 
MUST-
HCP 
Low 49 74.2% 2 3.0% 15 22.7% 66 
Medium 0 0.0% 6 100.0% 0 0.0% 6 
High 0 0.0% 0 0.0% 5 100.0% 5 
Total 49 63.6% 8 10.4% 20 26.0%  77 
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